StockGlow

Parabilis Medicines, Inc. (PBLS)

Parabilis Medicines, Inc.

$33.05+0.02%Healthcare
Compare PBLS with
StockGlow Score
91
Bullish
BearishBullish
1 year ago+21.2%

The outlook

Parabilis Medicines, Inc. currently reads as bullish based on above its 50- & 200-day averages, 86% of the way from its 52-week low to high, avg target +26% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range86% of the way from its 52-week low to high
Price targetAvg target +26% vs current price

Analyst price target

~12-month · 4 analysts
$41.75average target+26.3% vs now
Now $33.05
Low $40.00High $45.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$4.04B
52-wk high
$34.47
52-wk low
$24.51
50-day avg
$29.28
200-day avg
$29.28
Trailing P/E
—

Similar stocks

KLRAKailera Therapeutics, Inc.$16.95-0.59%COAGHemab Therapeutics Holdings, Inc.$46.56-1.93%EIKNEikon Therapeutics, Inc.$9.15-4.89%MANEVeradermics, Incorporated$105.66+0.98%AVLNAvalyn Pharma Inc.$28.49-2.82%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy